Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (4)

1

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

enthalten in: Blood advances | 2024

von Hamadani, M. | Spira, A. | Zhou, X. | +16

2

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma : a subgroup analysis from the LOTIS-2 study

enthalten in: Blood advances | 2022

von Alderuccio, J. | Ai, W. | Radford, J. | +14

3

CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy

enthalten in: Blood advances | 2020

von Thapa, B. | Caimi, P. | Ardeshna, K. | +4

ErratumIn: Blood Adv. 2020 Oct 13;4(19):4606. - PMID 32986790

4

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

enthalten in: Blood advances | 2020

von Santoro, A. | Mazza, R. | Pulsoni, A. | +16

1
[1]